Item Type | Name |
Academic Article
|
Suppressive effects of ansamycins on inducible nitric oxide synthase expression and the development of experimental autoimmune encephalomyelitis.
|
Academic Article
|
Noradrenergic regulation of inflammatory gene expression in brain.
|
Academic Article
|
Intrinsic regulation of brain inflammatory responses.
|
Academic Article
|
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists.
|
Academic Article
|
The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor gamma ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cells.
|
Academic Article
|
Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide.
|
Academic Article
|
The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.
|
Academic Article
|
PPARgamma as a therapeutic target in central nervous system diseases.
|
Academic Article
|
Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer's disease.
|
Academic Article
|
Reduction of amyloid angiopathy and Abeta plaque burden after enriched housing in TgCRND8 mice: involvement of multiple pathways.
|
Academic Article
|
Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
|
Academic Article
|
Inflammatory processes in Alzheimer's disease.
|
Academic Article
|
Long-term cognitive impairment, neuronal loss and reduced cortical cholinergic innervation after recovery from sepsis in a rodent model.
|
Academic Article
|
Switching on the lights for gene therapy.
|
Academic Article
|
PPARs in the brain.
|
Academic Article
|
The role of peroxisome proliferator-activated receptor-gamma (PPARgamma) in Alzheimer's disease: therapeutic implications.
|
Academic Article
|
Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism.
|
Academic Article
|
Loss of gamma-secretase function impairs endocytosis of lipoprotein particles and membrane cholesterol homeostasis.
|
Academic Article
|
NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits.
|
Academic Article
|
Neuroglia in neurodegeneration.
|
Academic Article
|
Noradrenergic depletion potentiates beta -amyloid-induced cortical inflammation: implications for Alzheimer's disease.
|
Academic Article
|
Neuroinflammatory processes in Alzheimer's disease.
|
Academic Article
|
Statins promote the degradation of extracellular amyloid {beta}-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion.
|
Academic Article
|
Restraint stress increases neuroinflammation independently of amyloid ? levels in amyloid precursor protein/PS1 transgenic mice.
|
Academic Article
|
Microglial activation in a neuroinflammational animal model of schizophrenia--a pilot study.
|
Academic Article
|
Nitration of tyrosine 10 critically enhances amyloid ? aggregation and plaque formation.
|
Academic Article
|
Opposing roles for CXCR3 signaling in central nervous system versus ocular inflammation mediated by the astrocyte-targeted production of IL-12.
|
Academic Article
|
TLR2 is a primary receptor for Alzheimer's amyloid ? peptide to trigger neuroinflammatory activation.
|
Academic Article
|
Nitric oxide decreases the enzymatic activity of insulin degrading enzyme in APP/PS1 mice.
|
Academic Article
|
Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice.
|
Academic Article
|
Norepinephrine increases I kappa B alpha expression in astrocytes.
|
Academic Article
|
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma.
|
Academic Article
|
Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis.
|
Academic Article
|
Beta-amyloid peptides decrease soluble guanylyl cyclase expression in astroglial cells.
|
Academic Article
|
PPAR?/RXRa-induced and CD36-mediated microglial amyloid-? phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.
|
Academic Article
|
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice.
|
Academic Article
|
Noradrenergic depletion increases inflammatory responses in brain: effects on IkappaB and HSP70 expression.
|
Academic Article
|
Noradrenaline induces expression of peroxisome proliferator activated receptor gamma (PPARgamma) in murine primary astrocytes and neurons.
|
Academic Article
|
Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase.
|
Academic Article
|
Interleukin-1 beta and lipopolysaccharide decrease soluble guanylyl cyclase in brain cells: NO-independent destabilization of protein and NO-dependent decrease of mRNA.
|
Academic Article
|
Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation.
|
Academic Article
|
Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
|
Academic Article
|
Systemic inflammation induces apoptosis with variable vulnerability of different brain regions.
|
Academic Article
|
Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma.
|
Academic Article
|
Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice.
|
Academic Article
|
Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
|
Academic Article
|
Disease-modifying therapies in Alzheimer's disease: how far have we come?
|
Academic Article
|
Imaging-guided gene therapy of experimental gliomas.
|
Academic Article
|
Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector.
|
Academic Article
|
Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders.
|
Academic Article
|
PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.
|
Academic Article
|
Noradrenergic denervation facilitates the release of acetylcholine and serotonin in the hippocampus: towards a mechanism underlying upregulations described in MCI patients.
|
Academic Article
|
PPARgamma and RXRgamma ligands act synergistically as potent antineoplastic agents in vitro and in vivo glioma models.
|
Academic Article
|
alpha-secretase mediated conversion of the amyloid precursor protein derived membrane stub C99 to C83 limits Abeta generation.
|
Academic Article
|
Norepinephrine enhances the LPS-induced expression of COX-2 and secretion of PGE2 in primary rat microglia.
|
Academic Article
|
Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.
|
Academic Article
|
Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine.
|
Academic Article
|
Distinct modulation of microglial amyloid ? phagocytosis and migration by neuropeptides (i).
|
Academic Article
|
Locus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice.
|
Academic Article
|
Neuroinflammatory and behavioural changes in the Atp7B mutant mouse model of Wilson's disease.
|
Academic Article
|
Extracellular phosphorylation of the amyloid ?-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Critical role of astroglial apolipoprotein E and liver X receptor-a expression for microglial A? phagocytosis.
|
Academic Article
|
Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease.
|
Academic Article
|
Glial cells in (patho)physiology.
|
Academic Article
|
Imaging microglial activation and glucose consumption in a mouse model of Alzheimer's disease.
|
Academic Article
|
A randomized, double blind, placebo-controlled trial of pioglitazone in combination with riluzole in amyotrophic lateral sclerosis.
|
Academic Article
|
Mrp14 deficiency ameliorates amyloid ? burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing.
|
Academic Article
|
CNS-targeted production of IL-17A induces glial activation, microvascular pathology and enhances the neuroinflammatory response to systemic endotoxemia.
|
Academic Article
|
Studying M1 and M2 states in adult microglia.
|
Concept
|
Disease Models, Animal
|
Concept
|
Animals, Newborn
|
Concept
|
Animals
|
Concept
|
Behavior, Animal
|
Concept
|
Models, Animal
|
Concept
|
Housing, Animal
|
Academic Article
|
Ear2 deletion causes early memory and learning deficits in APP/PS1 mice.
|
Academic Article
|
CXCR3 modulates glial accumulation and activation in cuprizone-induced demyelination of the central nervous system.
|
Academic Article
|
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction.
|
Academic Article
|
Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration.
|
Academic Article
|
Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.
|
Academic Article
|
CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.
|
Academic Article
|
Pan-PPAR modulation effectively protects APP/PS1 mice from amyloid deposition and cognitive deficits.
|
Academic Article
|
Innate immunity in Alzheimer's disease.
|
Academic Article
|
Neuroinflammation in Alzheimer's disease.
|
Academic Article
|
Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
|
Academic Article
|
?-Secretase processing of APP inhibits neuronal activity in the hippocampus.
|
Academic Article
|
Microglia in Alzheimer's disease: the good, the bad and the ugly.
|
Academic Article
|
Cyclodextrin promotes atherosclerosis regression via macrophage reprogramming.
|
Academic Article
|
Early Changes in Hippocampal Neurogenesis in Transgenic Mouse Models for Alzheimer's Disease.
|
Academic Article
|
Inflammasome activation and innate immunity in Alzheimer's disease.
|
Academic Article
|
Danger-associated molecular patterns in Alzheimer's disease.
|
Academic Article
|
IL-17A Promotes Granulocyte Infiltration, Myelin Loss, Microglia Activation, and Behavioral Deficits During Cuprizone-Induced Demyelination.
|
Academic Article
|
Personalized genetics of the cholinergic blockade of neuroinflammation.
|
Academic Article
|
Intramembranous processing by ?-secretase regulates reverse signaling of ephrin-B2 in migration of microglia.
|
Academic Article
|
Inflammasome-derived cytokine IL18 suppresses amyloid-induced seizures in Alzheimer-prone mice.
|
Academic Article
|
Activation of the NLRP3 inflammasome in microglia: the role of ceramide.
|
Academic Article
|
United Again: STING and the Police.
|
Academic Article
|
Microglia-derived ASC specks cross-seed amyloid-? in Alzheimer's disease.
|
Academic Article
|
Inflammasome signalling in brain function and neurodegenerative disease.
|
Academic Article
|
Transcriptome analysis of alcohol-treated microglia reveals downregulation of beta amyloid phagocytosis.
|
Academic Article
|
Proteome profiling of s-nitrosylated synaptosomal proteins by isobaric mass tags.
|
Academic Article
|
Targeting Neuroinflammation to Treat Alzheimer's Disease.
|
Academic Article
|
Neuroinflammatory responses in Alzheimer's disease.
|
Academic Article
|
Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration.
|
Academic Article
|
Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-? plaques: A potential role in shaping plaque pathology?
|
Academic Article
|
Variability and temporal dynamics of novel object recognition in aging male C57BL/6 mice.
|
Academic Article
|
The NMDA receptor antagonist Radiprodil reverses the synaptotoxic effects of different amyloid-beta (A?) species on long-term potentiation (LTP).
|
Academic Article
|
Microglia in Alzheimer's disease.
|
Academic Article
|
Microglia take centre stage in neurodegenerative disease.
|
Academic Article
|
CNS-Specific Synthesis of Interleukin 23 Induces a Progressive Cerebellar Ataxia and the Accumulation of Both T and B Cells in the Brain: Characterization of a Novel Transgenic Mouse Model.
|
Academic Article
|
Elevated levels of Secreted-Frizzled-Related-Protein 1 contribute to Alzheimer's disease pathogenesis.
|
Academic Article
|
Systemic inflammation impairs microglial A? clearance through NLRP3 inflammasome.
|
Academic Article
|
Microglia in Neurodegenerative Disorders.
|
Academic Article
|
In Vivo Phagocytosis Analysis of Amyloid Beta.
|
Academic Article
|
A rare heterozygous TREM2 coding variant identified in familial clustering of dementia affects an intrinsically disordered protein region and function of TREM2.
|
Academic Article
|
Quantitative proteomics of synaptosome S-nitrosylation in Alzheimer's disease.
|
Academic Article
|
The role of innate immune responses and neuroinflammation in amyloid accumulation and progression of Alzheimer's disease.
|
Academic Article
|
Norepinephrine as a modulator of microglial dynamics.
|
Academic Article
|
Inflammasome-mediated innate immunity in Alzheimer's disease.
|
Academic Article
|
NLRP3 inflammasome activation drives tau pathology.
|
Academic Article
|
Vaccination with (1-11)E2 in alum efficiently induces an antibody response to ?-amyloid without affecting brain ?-amyloid load and microglia activation in 3xTg mice.
|
Academic Article
|
Soluble A? oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
|
Academic Article
|
?-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia.
|
Academic Article
|
Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease.
|
Academic Article
|
Enduring Changes in Neuronal Function upon Systemic Inflammation Are NLRP3 Inflammasome Dependent.
|
Academic Article
|
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.
|
Academic Article
|
mTOR-dependent translation amplifies microglia priming in aging mice.
|
Academic Article
|
Deletion of the inflammatory S100-A9/MRP14 protein does not influence survival in hSOD1G93A ALS mice.
|
Academic Article
|
Astrocyte-specific expression of interleukin 23 leads to an aggravated phenotype and enhanced inflammatory response with B cell accumulation in the EAE model.
|
Academic Article
|
In vivo mechanisms of cortical network dysfunction induced by systemic inflammation.
|
Academic Article
|
Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing.
|
Academic Article
|
Differential interaction with TREM2 modulates microglial uptake of modified A? species.
|
Academic Article
|
Microglial NLRP3 Inflammasome Activation upon TLR2 and TLR5 Ligation by Distinct a-Synuclein Assemblies.
|
Academic Article
|
Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus.
|
Academic Article
|
Proteopathic tau primes and activates interleukin-1? via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway.
|
Academic Article
|
Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes.
|
Academic Article
|
SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation.
|
Academic Article
|
TREM2 modulates differential deposition of modified and non-modified A? species in extracellular plaques and intraneuronal deposits.
|
Academic Article
|
Microglial PD-1 stimulation by astrocytic PD-L1 suppresses neuroinflammation and Alzheimer's disease pathology.
|
Academic Article
|
Inflammasome activation in neurodegenerative diseases.
|
Academic Article
|
Reactive microglia are the major source of tumor necrosis factor alpha and contribute to astrocyte dysfunction and acute seizures in experimental temporal lobe epilepsy.
|
Academic Article
|
ApoE4 makes microglia trem2bling.
|
Academic Article
|
NLRP3-directed antisense oligonucleotides reduce microglial immunoactivities in vitro.
|
Academic Article
|
ARG1-expressing microglia show a distinct molecular signature and modulate postnatal development and function of the mouse brain.
|
Academic Article
|
Characterizing microglial senescence: Tau as a key player.
|
Academic Article
|
Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer's disease.
|
Academic Article
|
Immune Activation in Alzheimer Disease.
|
Academic Article
|
The endotoxin hypothesis of Alzheimer's disease.
|
Academic Article
|
TREM1 is the new kid on the block for the aging-associated innate immune response and Alzheimer's disease.
|
Academic Article
|
Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes.
|
Academic Article
|
Tracking neuroinflammatory biomarkers in Alzheimer's disease: a strategy for individualized therapeutic approaches?
|
Academic Article
|
Inflammatory aspects of Alzheimer's disease.
|
Academic Article
|
The putative contribution of cellular senescence to driving tauopathies.
|
Academic Article
|
Tunneling Nanotubes in the Brain.
|
Academic Article
|
The impact of neuroinflammation on neuronal integrity.
|
Academic Article
|
Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference.
|